Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

EPANOVA in Crohn's Disease, Study 1 (EPIC-1)

This study has been completed.
Sponsor:
Information provided by:
Tillotts Pharma AG
ClinicalTrials.gov Identifier:
NCT00613197
First received: January 15, 2008
Last updated: April 3, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):